{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:52:11Z","timestamp":1777870331871,"version":"3.51.4"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-024-02062-y","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T14:03:34Z","timestamp":1724421814000},"page":"1911-1919","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intradialytic serum phosphate variations are associated with low PTH levels"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2298-1420","authenticated-orcid":false,"given":"Gianmarco","family":"Lombardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Votrico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro Manuel","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Tassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Lissoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Ortalda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Gambaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"key":"2062_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2337\/diaspect.21.1.19","volume":"21","author":"S Tomasello","year":"2008","unstructured":"Tomasello S (2008) Secondary hyperparathyroidism and chronic kidney disease. Diabetes Spectr 21:19\u201325. https:\/\/doi.org\/10.2337\/diaspect.21.1.19","journal-title":"Diabetes Spectr"},{"key":"2062_CR2","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/S0272-6386(97)90459-5","volume":"29","author":"MM Salem","year":"1997","unstructured":"Salem MM (1997) Hyperparathyroidism in the hemodialysis population: a survey of 612 patients. Am J Kidney Dis 29:862\u2013865. https:\/\/doi.org\/10.1016\/S0272-6386(97)90459-5","journal-title":"Am J Kidney Dis"},{"key":"2062_CR3","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1093\/ckj\/sfab006","volume":"14","author":"Y Xu","year":"2021","unstructured":"Xu Y, Evans M, Soro M et al (2021) Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease. Clin Kidney J 14:2213\u20132220. https:\/\/doi.org\/10.1093\/ckj\/sfab006","journal-title":"Clin Kidney J"},{"key":"2062_CR4","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/ki.2008.64","volume":"73","author":"CP Kovesdy","year":"2008","unstructured":"Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K (2008) Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int 73:1296\u20131302. https:\/\/doi.org\/10.1038\/ki.2008.64","journal-title":"Kidney Int"},{"key":"2062_CR5","doi-asserted-by":"publisher","first-page":"c159","DOI":"10.1159\/000099006","volume":"105","author":"S Khan","year":"2007","unstructured":"Khan S (2007) secondary hyperparathyroidism is associated with higher cost of care among chronic kidney disease patients with cardiovascular comorbidities. Nephron Clin Pract 105:c159\u2013c164. https:\/\/doi.org\/10.1159\/000099006","journal-title":"Nephron Clin Pract"},{"key":"2062_CR6","doi-asserted-by":"publisher","unstructured":"Joy MS, Karagiannis PC, Peyerl FW (2007) Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. J Manag Care Pharm 13:397\u2013411. https:\/\/doi.org\/10.18553\/jmcp.2007.13.5.397","DOI":"10.18553\/jmcp.2007.13.5.397"},{"key":"2062_CR7","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s40266-019-00696-3","volume":"36","author":"A Galassi","year":"2019","unstructured":"Galassi A, Ciceri P, Fasulo E et al (2019) Management of secondary hyperparathyroidism in chronic kidney disease: a focus on the elderly. Drugs Aging 36:885\u2013895. https:\/\/doi.org\/10.1007\/s40266-019-00696-3","journal-title":"Drugs Aging"},{"key":"2062_CR8","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1053\/ajkd.2001.20740","volume":"37","author":"E Slatopolsky","year":"2001","unstructured":"Slatopolsky E, Brown A, Dusso A (2001) Role of phosphorus in the pathogenesis of secondary hyperparathyroidism. Am J Kidney Dis 37:S54\u2013S57. https:\/\/doi.org\/10.1053\/ajkd.2001.20740","journal-title":"Am J Kidney Dis"},{"key":"2062_CR9","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.ekir.2019.06.002","volume":"4","author":"FC Barreto","year":"2019","unstructured":"Barreto FC, Barreto DV, Massy ZA, Dr\u00fceke TB (2019) Strategies for phosphate control in patients With CKD. Kidney Int Rep 4:1043\u20131056. https:\/\/doi.org\/10.1016\/j.ekir.2019.06.002","journal-title":"Kidney Int Rep"},{"key":"2062_CR10","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/ndt\/17.6.1037","volume":"17","author":"J Gutzwiller","year":"2002","unstructured":"Gutzwiller J, Schneditz D, Huber AR et al (2002) Estimating phosphate removal in haemodialysis: an additional tool to quantify dialysis dose. Nephrol Dial Transplant 17:1037\u20131044. https:\/\/doi.org\/10.1093\/ndt\/17.6.1037","journal-title":"Nephrol Dial Transplant"},{"key":"2062_CR11","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1093\/ndt\/gfac223","volume":"37","author":"JT Daugirdas","year":"2022","unstructured":"Daugirdas JT (2022) Comparison of measured vs kinetic-model predicted phosphate removal during hemodialysis and hemodiafiltration. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc 37:2522\u20132527. https:\/\/doi.org\/10.1093\/ndt\/gfac223","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"2062_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000487108","volume":"43","author":"RM Elias","year":"2018","unstructured":"Elias RM, Alvares VRC, Moys\u00e9s RMA (2018) Phosphate removal during conventional hemodialysis: a decades-old misconception. Kidney Blood Press Res 43:110\u2013114. https:\/\/doi.org\/10.1159\/000487108","journal-title":"Kidney Blood Press Res"},{"key":"2062_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000503623","volume":"49","author":"M Debowska","year":"2020","unstructured":"Debowska M, Dai L, Wojcik-Zaluska A et al (2020) Association between biomarkers of mineral and bone metabolism and removal of calcium and phosphate in hemodialysis. Blood Purif 49:71\u201378. https:\/\/doi.org\/10.1159\/000503623","journal-title":"Blood Purif"},{"key":"2062_CR14","unstructured":"https:\/\/www.crea.gov.it\/-\/tabella-di-composizione-degli-alimenti"},{"key":"2062_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ki.2008.130","volume":"74","author":"KA Hruska","year":"2008","unstructured":"Hruska KA, Mathew S, Lund R et al (2008) Hyperphosphatemia of chronic kidney disease. Kidney Int 74:148\u2013157. https:\/\/doi.org\/10.1038\/ki.2008.130","journal-title":"Kidney Int"},{"key":"2062_CR16","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T, Wahl P, Vargas GS et al (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79:1370\u20131378. https:\/\/doi.org\/10.1038\/ki.2011.47","journal-title":"Kidney Int"},{"key":"2062_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis Off J Natl Kidney Found 31:607\u2013617. https:\/\/doi.org\/10.1053\/ajkd.1998.v31.pm9531176","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"2062_CR18","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1681\/ASN.2004070602","volume":"16","author":"B Kestenbaum","year":"2005","unstructured":"Kestenbaum B, Sampson JN, Rudser KD et al (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol JASN 16:520\u2013528. https:\/\/doi.org\/10.1681\/ASN.2004070602","journal-title":"J Am Soc Nephrol JASN"},{"key":"2062_CR19","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","volume":"109","author":"CM Shanahan","year":"2011","unstructured":"Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM (2011) Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 109:697\u2013711. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.234914","journal-title":"Circ Res"},{"key":"2062_CR20","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1042\/CS20160807","volume":"131","author":"JM Mart\u00ednez-Moreno","year":"1979","unstructured":"Mart\u00ednez-Moreno JM, Herencia C, de Oca AM et al (1979) High phosphate induces a pro-inflammatory response by vascular smooth muscle cells and modulation by vitamin D derivatives. Clin Sci Lond Engl 131:1449\u20131463. https:\/\/doi.org\/10.1042\/CS20160807","journal-title":"Clin Sci Lond Engl"},{"key":"2062_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group","year":"2017","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017) KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 7:1\u201359","journal-title":"Kidney Int Suppl"},{"key":"2062_CR22","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/ki.1986.252","volume":"30","author":"JA Ramirez","year":"1986","unstructured":"Ramirez JA, Emmett M, White MG et al (1986) The absorption of dietary phosphorus and calcium in hemodialysis patients. Kidney Int 30:753\u2013759. https:\/\/doi.org\/10.1038\/ki.1986.252","journal-title":"Kidney Int"},{"key":"2062_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000067866","volume":"21","author":"FA Gotch","year":"2003","unstructured":"Gotch FA, Panlilio F, Sergeyeva O et al (2003) A kinetic model of inorganic phosphorus mass balance in hemodialysis therapy. Blood Purif 21:51\u201357. https:\/\/doi.org\/10.1159\/000067866","journal-title":"Blood Purif"},{"key":"2062_CR24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1681\/ASN.2011070688","volume":"23","author":"JT Daugirdas","year":"2012","unstructured":"Daugirdas JT, Chertow GM, Larive B et al (2012) Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. J Am Soc Nephrol JASN 23:727\u2013738. https:\/\/doi.org\/10.1681\/ASN.2011070688","journal-title":"J Am Soc Nephrol JASN"},{"key":"2062_CR25","first-page":"M463","volume":"37","author":"NK Man","year":"1991","unstructured":"Man NK, Chauveau P, Kuno T et al (1991) Phosphate removal during hemodialysis, hemodiafiltration, and hemofiltration. A reappraisal. ASAIO Trans 37:M463-465","journal-title":"ASAIO Trans"},{"key":"2062_CR26","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1681\/ASN.V451214","volume":"4","author":"CA DeSoi","year":"1993","unstructured":"DeSoi CA, Umans JG (1993) Phosphate kinetics during high-flux hemodialysis. J Am Soc Nephrol JASN 4:1214\u20131218. https:\/\/doi.org\/10.1681\/ASN.V451214","journal-title":"J Am Soc Nephrol JASN"},{"key":"2062_CR27","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1681\/ASN.V95859","volume":"9","author":"A Pierratos","year":"1998","unstructured":"Pierratos A, Ouwendyk M, Francoeur R et al (1998) Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol JASN 9:859\u2013868. https:\/\/doi.org\/10.1681\/ASN.V95859","journal-title":"J Am Soc Nephrol JASN"},{"key":"2062_CR28","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1046\/j.1523-1755.1998.00875.x","volume":"53","author":"I Mucsi","year":"1998","unstructured":"Mucsi I, Hercz G, Uldall R et al (1998) Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 53:1399\u20131404. https:\/\/doi.org\/10.1046\/j.1523-1755.1998.00875.x","journal-title":"Kidney Int"},{"key":"2062_CR29","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5414\/CN108629","volume":"85","author":"G Block","year":"2016","unstructured":"Block G, Do TP, Collins AJ et al (2016) Co-trending of parathyroid hormone and phosphate in patients receiving hemodialysis. Clin Nephrol 85:142\u2013151. https:\/\/doi.org\/10.5414\/CN108629","journal-title":"Clin Nephrol"},{"key":"2062_CR30","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1681\/ASN.V1341046","volume":"13","author":"R Minutolo","year":"2002","unstructured":"Minutolo R, Bellizzi V, Cioffi M et al (2002) Postdialytic rebound of serum phosphorus: pathogenetic and clinical insights. J Am Soc Nephrol JASN 13:1046\u20131054. https:\/\/doi.org\/10.1681\/ASN.V1341046","journal-title":"J Am Soc Nephrol JASN"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02062-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-02062-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02062-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:33Z","timestamp":1777564413000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/37\/7\/1911\/8306327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["2062"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-02062-y","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]},"assertion":[{"value":"8 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest regarding the content of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approval was granted by the Committee for the Approval of the Research on Human Subjects of the University of Verona (Prot no. 6204). Our study was conducted in accordance with the standards as laid down in the in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants prior to their enrollment in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}}]}}